Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102, KP-102 LN, KP-102D, KP-102LN

Drugs in R and D

Volumn 5, Issue 4, 2004, Pages 236-239

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; KP 102 D; KP 102 LN; KP 102D; KP 102LN; PRALMORELIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AFRICA; ARTICLE; AUSTRALIA; BITTER TASTE; BODY TEMPERATURE DISORDER; BONE GROWTH; CANADA; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DRUG APPROVAL; DRUG EFFECT; DRUG HALF LIFE; DRUG INDICATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG MECHANISM; DRUG SYNTHESIS; EUROPE; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEAT SENSATION; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; JAPAN; LICENCE; MOLECULAR SIZE; MUSCLE GROWTH; NEUROENDOCRINE DISEASE; NEW ZEALAND; NONHUMAN; PATENT; PHARMACODYNAMICS; PITUITARY DWARFISM; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SHORT STATURE; SOUTH AND CENTRAL AMERICA; SWEAT GLAND DISEASE; TASTE DISORDER; UNITED STATES;

ANIMALS; CLINICAL TRIALS; DWARFISM, PITUITARY; HUMAN GROWTH HORMONE; HUMANS; OLIGOPEPTIDES;

EID: 4143149579     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200405040-00011     Document Type: Article

References (7)

1. Jordan RA, Kagan N, Scatina J. Metabolism and excretion of a growth hormone releasing peptide, GPA-748 or GHRP-2, in rats and monkeys following intravenous, subcutaneous and oral administration. 7th North American ISSX Meeting 10: 340, 20 Oct 1996
2. Pihoker C, Badger TM, Reynolds GA. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. Journal of Endocrinology 155: 79-86, Oct 1997
3. Chihara K, Iida K, Okimura Y, et al. Usefullness of growth hormone releasing peptide-2 (KP-102) stimulation test for diagnosis of severe growth hormone deficiency. 84th Annual Meeting of the Endocrine Society: 33, 19 Jun 2002
4. Tiulpakov AN, Brook CGD, Pringle PJ. GH response to intravenous bolus infusions of GH releasing hormone, GH releasing peptide 2 and combination of GHRH and GHRP-2. European Journal of Endocrinology 130 (Suppl. 2): 190, Jun 1994
5. Pihoker C, Kearns GL, French D. Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. Journal of Clinical Endocrinology and Metabolism 83: 1168-1172, Apr 1998
6. Gordo RG, Aguiar-Oliveira MH, Hayashida CY, et al. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. Journal of Clinical Endocrinology and Metabolism 86: 3279-3283, Jul 2001
7. Meric V, Cassorla F, Bowers CY, et al. Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in GH-deficient children. Pediatric Research 49: 129, Part 2, Jun 2001